Cargando…

TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation

Nonalcoholic steatohepatitis (NASH) is a chronic liver disease associated with dysregulation of liver metabolism and inflammation. G-protein coupled bile acid receptor 1 (TGR5) is a cell surface receptor that is involved in multiple metabolic pathways. However, the functions of TGR5 in regulating ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Yong, Su, Wantong, Zhang, Lei, Shi, Chengyu, Zhou, Jinren, Wang, Peng, Wang, Hao, Shi, Xiaoli, Wei, Song, Wang, Qi, Auwerx, Johan, Schoonjans, Kristina, Yu, Yue, Pan, Rui, Zhou, Haoming, Lu, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937818/ https://www.ncbi.nlm.nih.gov/pubmed/33692776 http://dx.doi.org/10.3389/fimmu.2020.609060

Ejemplares similares

Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
por: Torres, Sandra, et al.
Publicado: (2022)

TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
por: Harach, Taoufiq, et al.
Publicado: (2012)

Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling
por: Wang, Peng, et al.
Publicado: (2021)

Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice
por: Lin, Yanke, et al.
Publicado: (2021)

Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome
por: Hong, Chung Hwan, et al.
Publicado: (2021)

TGR5 deficiency aggravates hepatic ischemic/reperfusion injury via inhibiting SIRT3/FOXO3/HIF-1ɑ pathway
por: Wang, Qi, et al.
Publicado: (2020)

NLRP3 Inflammasome Formation and Activation in Nonalcoholic Steatohepatitis: Therapeutic Target for Antimetabolic Syndrome Remedy FTZ
por: Chen, Yu, et al.
Publicado: (2018)

Diabetes induces hepatocyte pyroptosis by promoting oxidative stress-mediated NLRP3 inflammasome activation during liver ischaemia and reperfusion injury
por: Shi, Chengyu, et al.
Publicado: (2020)

Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
por: Wang, Qi, et al.
Publicado: (2019)

Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
por: Li, Haiou, et al.
Publicado: (2020)

PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis
por: Jin, Kangpeng, et al.
Publicado: (2020)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum
por: Jin, Kangpeng, et al.
Publicado: (2022)

Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway
por: Qiu, Tianming, et al.
Publicado: (2018)

Deficiency of the Purinergic Receptor 2X(7) Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the NLRP3 Inflammasome
por: Blasetti Fantauzzi, Claudia, et al.
Publicado: (2017)

Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome
por: Yang, Gabsik, et al.
Publicado: (2020)

Lycopene alleviates hepatic ischemia reperfusion injury via the Nrf2/HO-1 pathway mediated NLRP3 inflammasome inhibition in Kupffer cells
por: Xue, Rong, et al.
Publicado: (2021)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
por: Li, Dan-Pei, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis
por: Liu, Wenli, et al.
Publicado: (2018)

Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
por: Shi, Yi-wen, et al.
Publicado: (2023)

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
por: Zhou, Keren, et al.
Publicado: (2016)

TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue
por: Velazquez-Villegas, Laura A., et al.
Publicado: (2018)

Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90
por: Ma, Ji, et al.
Publicado: (2023)

Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse
por: Zhou, Lishan, et al.
Publicado: (2017)

FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis
por: Liu, Cong, et al.
Publicado: (2023)

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages
por: Gangopadhyay, Anu, et al.
Publicado: (2022)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression
por: Wang, Qi, et al.
Publicado: (2022)

Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Zhou, Lishan, et al.
Publicado: (2018)

FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection
por: Kang, Ju-Hee, et al.
Publicado: (2021)

Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials
por: He, Lingling, et al.
Publicado: (2016)

Compound 18 Improves Glucose Tolerance in a Hepatocyte TGR5-dependent Manner in Mice
por: Holter, Marlena M., et al.
Publicado: (2020)

Myricetin Modulates Macrophage Polarization and Mitigates Liver Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis
por: Yao, Qunyan, et al.
Publicado: (2020)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways
por: Dong, Zhixia, et al.
Publicado: (2020)

RelA/MicroRNA-30a/NLRP3 signal axis is involved in rheumatoid arthritis via regulating NLRP3 inflammasome in macrophages
por: Yang, Qiudong, et al.
Publicado: (2021)

Chronic inflammation as a molecular basis of nonalcoholic steatohepatitis: role of macrophages and fibroblasts in the liver
por: Itoh, Michiko, et al.
Publicado: (2020)

Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization
por: Han, Yuqiu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ii2usrmj9n218d10sbbo3us9l5